Neo-adjuvant chemoradiotherapy followed by surgery in treatment of advanced esophageal carcinoma

National Medical Journal of China

Volumn 88, Issue 45, 2008, Pages 3182-3185

  Yang, Hong ^a   Fu, Jian Hua ^b   Hu, Yi ^b   Lin, Peng ^b   Liu, Meng Zhong ^b   Li, Qun ^b   Fang, Zhi Chao ^b   Hu, Yong Hong ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b NONE

Author keywords

Drug therapy; Esophageal neoplasms; Radiotherapy; Surgical procedures, operative

Indexed keywords

CISPLATIN; FLUOROURACIL; NAVELBINE;

ADVANCED CANCER; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG FATALITY; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HEART ARRHYTHMIA; HUMAN; INCIDENCE; LUNG INFECTION; LUNG TOXICITY; LYMPHADENECTOMY; POSTOPERATIVE INFECTION; PREOPERATIVE RADIOTHERAPY; RADIATION DOSE; SURGICAL MORTALITY; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; MALE; MIDDLE AGED;

ADULT; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 77954825169     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med, 1996, 335: 462-467.
2. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamouscell cancer of the esophagus. N Engl J Med, 1997, 337: 161-167.
3. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol, 2005, 6: 659-668.
4. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer, 1994, 73: 1779-1784. (Pubitemid 24101950)
5. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophagea cancer. World J Surg, 1992, 16: 1104-1109.
6. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol, 2001, 19: 305-313.
7. van de Schoot, L, Romme EA, van der Sangen MJ, et al. A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer. Ann Surg Oncol, 2008, 15: 88-95.
8. Mulligan ED, Dunne B, Griffin M, et al. Margin involvement and outcome in oesophageal carcinoma: a 10-year experience in a specialist unit. Eur J Surg Oncol, 2004, 30: 313-317.
9. Hofstetter W, Swisher SG, Correa AM, et al. Treatment outcomes of resected esophageal cancer. Ann Surg, 2002, 236: 376-384.
10. Kleinberg L, Knisely JP, Heitmiller R, et al. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys, 2003, 56: 328-334. (Pubitemid 36542889)
11. Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly unproved survival. J Clin Oncol, 2005, 23: 4330-4337.
12. Hammoud ZT, Kesler KA, Ferguson MK, et al. Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus, 2006, 19: 69-72.
13. Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut, 2004, 53: 925-930.